Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Natural Alternatives International (NAII) Long-Term Debt Issuances (2021)

Natural Alternatives International (NAII) has disclosed Long-Term Debt Issuances for 1 consecutive years, with $10.0 million as the latest value for Q3 2021.

  • Quarterly Long-Term Debt Issuances changed N/A to $10.0 million in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $10.0 million through Jun 2022, changed N/A year-over-year, with the annual reading at $10.0 million for FY2022, N/A changed from the prior year.
  • Long-Term Debt Issuances hit $10.0 million in Q3 2021 for Natural Alternatives International.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $10.0 million in Q3 2021 to a low of $10.0 million in Q3 2021.